Biotech coworking provider NSG BioLabs, from Singapore, just completed a US$ 14,5 Mio financing round.

The coworking operator provides biotech startups and multinational companies private and shared laboratory spaces, offices, equipment, privileged access to service providers and suppliers, and community engagement. NSG BioLabs currently houses over 40 innovative companies in its coworking biotech laboratory in Singapore.

After a first site opening in November 2019, NSG BioLabs expanded with its second site in August 2021 and a third one in 2023 . The three sites cover a total surface of 3.500 m2.

Asian private equity firm Celadon Partners led the funding round, along with ClavystBio.